XML 37 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Net income $ 133,137 $ 77,795 $ 76,077
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 224,797 198,792 182,972
Accretion of asset retirement obligation 6,164 5,257 3,977
Stock-based compensation 15,478 11,646 9,168
Income attributable to sale of tax benefits, net of interest expense (23,462) (13,153) (12,201)
Equity in losses (earnings) of investees, net (35) 3,072 2,624
Mark-to-market of derivative instruments (2,206) 1,613 741
Loss (gain) on disposal of property, plant and equipment 35 (89) 0
Write-off of unsuccessful exploration activities 3,733 828 0
Impairment of long-lived assets 0 32,648 0
Loss from prepayment of a long-term loan 0 1,102 0
Loss (gain) on severance pay fund asset 154 1,019 (1,335)
Deferred income tax provision (6,017) (18,979) (3,115)
Liability for unrecognized tax benefits 2,114 829 3,760
Other 0 575 526
Changes in operating assets and liabilities, net of businesses acquired:      
Receivables (97,640) (19,929) 26,738
Costs and estimated earnings in excess of billings on uncompleted contracts (1,962) (6,713) 14,852
Inventories (22,205) 5,613 4,127
Prepaid expenses and other (3,248) 4,888 (19,105)
Change in operating lease right of use asset 3,761 2,717 3,010
Deposits and other (7,900) 2,571 (4,154)
Accounts payable and accrued expenses 68,590 (2,045) (21,936)
Billings in excess of costs and estimated earnings on uncompleted contracts 9,884 (463) (1,931)
Liabilities for severance pay (989) (2,861) (3,055)
Change in operating lease liabilities (3,435) (3,581) (2,816)
Other liabilities, net 10,653 (2,178) (102)
Net cash provided by operating activities 309,401 280,974 258,822
Cash flows from investing activities:      
Purchase of marketable securities 0 (19,192) (60,070)
Maturities of marketable securities 0 32,645 16,272
Sale of marketable securities 0 29,355 0
Capital expenditures (618,383) (563,476) (419,272)
Cash received from insurance recoveries 0 600 0
Investment in unconsolidated companies (10,181) (4,509) (6,401)
Cash paid for acquisition of a business, net of cash acquired 0 0 (171,000)
Decrease (increase) in severance pay fund asset, net of payments made to retired employees 221 1,171 3,189
Other investing activities 0 0 (911)
Net cash used in investing activities (628,343) (523,406) (638,193)
Cash flows from financing activities:      
Proceeds from long-term loans, net of transaction costs 149,837 135,259 275,000
Proceeds from exercise of options by employees 314 39 0
Proceeds from issuance of common stock, net of stock issuance costs 341,671 0 311
Proceeds from issuance of convertible notes, net of transaction costs 0 419,698 0
Purchase of capped call instruments 0 (24,538) 0
Purchase of treasury stock 0 (17,964) 0
Proceeds from the sale of limited liability company interest, net of transaction costs 42,329 50,330 37,141
Repayments of commercial paper and prepayments of long-term debt 0 (219,126) 0
Proceeds from issuance of commercial paper, net of transaction costs 99,971 0 0
Proceeds from revolving credit lines with banks 55,000 0 0
Repayment of revolving credit lines with banks (35,000) 0 0
Cash received from noncontrolling interest 7,341 5,443 5,390
Transaction with noncontrolling interest (30,000) 0 0
Repayments of long-term debt and financing liability (207,039) (185,163) (93,046)
Cash paid to noncontrolling interest (9,856) (5,880) (6,903)
Payments under finance lease obligations (1,963) (2,983) (3,181)
Deferred debt issuance costs (4,229) (1,699) (1,341)
Cash dividends paid (28,412) (27,143) (26,986)
Net cash provided by (used in) financing activities 379,964 126,273 186,385
Effect of exchange rate changes on cash and cash equivalents and restricted cash and cash equivalents 72 (609) (348)
Net change in cash and cash equivalents and restricted cash and cash equivalents 61,094 (116,768) (193,334)
Cash and cash equivalents and restricted cash and cash equivalents at beginning of period 226,676 343,444 536,778
Cash and cash equivalents and restricted cash and cash equivalents at end of period 287,770 226,676 343,444
Supplemental disclosure of cash flow information:      
Interest, net of interest capitalized 72,236 69,132 66,627
Income taxes, net 26,250 29,004 34,357
Supplemental non-cash investing and financing activities:      
Increase (decrease) in accounts payable related to purchases of property, plant and equipment (12,417) 4,764 7,976
Right of use assets obtained in exchange for new lease liabilities 6,402 8,759 6,175
Increase in asset retirement cost and asset retirement obligation $ 10,546 $ 7,512 $ 12,153